187 related articles for article (PubMed ID: 27535001)
1. Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport.
Lionarons DA; Heger M; van Golen RF; Alles LK; van der Mark VA; Kloek JJ; de Waart DR; Marsman HA; Rusch H; Verheij J; Beuers U; Paulusma CC; van Gulik TM
Sci Rep; 2016 Aug; 6():31829. PubMed ID: 27535001
[TBL] [Abstract][Full Text] [Related]
2. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
[TBL] [Abstract][Full Text] [Related]
3. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
[TBL] [Abstract][Full Text] [Related]
4. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
[TBL] [Abstract][Full Text] [Related]
5. A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver.
Rodríguez-Ortigosa CM; Celay J; Olivas I; Juanarena N; Arcelus S; Uriarte I; Marín JJ; Avila MA; Medina JF; Prieto J
Gastroenterology; 2014 Nov; 147(5):1084-93. PubMed ID: 25066374
[TBL] [Abstract][Full Text] [Related]
6. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.
Schaap FG; van der Gaag NA; Gouma DJ; Jansen PL
Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005
[TBL] [Abstract][Full Text] [Related]
7. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
8. Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis.
Dumaswala R; Berkowitz D; Heubi JE
Hepatology; 1996 Mar; 23(3):623-9. PubMed ID: 8617445
[TBL] [Abstract][Full Text] [Related]
9. Taurine conjugate of 3 alpha,6 beta,7 beta-trihydroxy-5 beta,22-cholen-24-oic acid (tauro-delta 22-beta-muricholate): the major bile acid in the serum of female rats treated with alpha-naphthylisothiocyanate and its secretion by liver slices.
Thompson MB; Davis DG; Morris RW
J Lipid Res; 1993 Apr; 34(4):553-61. PubMed ID: 8496661
[TBL] [Abstract][Full Text] [Related]
10. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
[TBL] [Abstract][Full Text] [Related]
11. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
[TBL] [Abstract][Full Text] [Related]
12. Hepatic handling of bile salts and protein in the rat during intrahepatic cholestasis.
Goldsmith MA; Huling S; Jones AL
Gastroenterology; 1983 May; 84(5 Pt 1):978-86. PubMed ID: 6832571
[TBL] [Abstract][Full Text] [Related]
13. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
Okushin K; Tsutsumi T; Enooku K; Fujinaga H; Kado A; Shibahara J; Fukayama M; Moriya K; Yotsuyanagi H; Koike K
J Gastroenterol; 2016 Aug; 51(8):808-18. PubMed ID: 26601667
[TBL] [Abstract][Full Text] [Related]
14. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.
Kitani K; Kanai S; Sato Y; Ohta M
Hepatology; 1994 Apr; 19(4):1007-12. PubMed ID: 8138240
[TBL] [Abstract][Full Text] [Related]
15. 12α-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats.
Lee JY; Shimizu H; Hagio M; Fukiya S; Watanabe M; Tanaka Y; Joe GH; Iwaya H; Yoshitsugu R; Kikuchi K; Tsuji M; Baba N; Nose T; Tada K; Hanai T; Hori S; Takeuchi A; Furukawa Y; Shirouchi B; Sato M; Ooka T; Ogura Y; Hayashi T; Yokota A; Ishizuka S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158811. PubMed ID: 32896622
[TBL] [Abstract][Full Text] [Related]
16. Adaptive changes of hepatic bile salt transport in a model of reversible interruption of the enterohepatic circulation in the rat.
Accatino L; Hono J; Koenig C; Pizarro M; Rodriguez L
J Hepatol; 1993 Aug; 19(1):95-104. PubMed ID: 8301050
[TBL] [Abstract][Full Text] [Related]
17. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion.
Pawlikowska L; Groen A; Eppens EF; Kunne C; Ottenhoff R; Looije N; Knisely AS; Killeen NP; Bull LN; Elferink RP; Freimer NB
Hum Mol Genet; 2004 Apr; 13(8):881-92. PubMed ID: 14976163
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic transport of bile salt. Effect of protein synthesis inhibition on excretion of bile salts and their binding to liver surface membrane fractions.
Gonzalez MC; Sutherland E; Simon FR
J Clin Invest; 1979 Apr; 63(4):684-94. PubMed ID: 438330
[TBL] [Abstract][Full Text] [Related]
19. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
Fattinger K; Funk C; Pantze M; Weber C; Reichen J; Stieger B; Meier PJ
Clin Pharmacol Ther; 2001 Apr; 69(4):223-31. PubMed ID: 11309550
[TBL] [Abstract][Full Text] [Related]
20. Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model.
Kodama M; Kanno K; Kishikawa N; Takei H; Nittono H; Tazuma S
J Hepatobiliary Pancreat Sci; 2019 Dec; 26(12):557-567. PubMed ID: 31562685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
